Sterling Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
9,723
+1,622
| +20% | +$204K | 0.02% | 557 |
|
|
2025
Q1 | $1.11M | Sell |
8,101
-535
| -6% | -$73.2K | 0.02% | 581 |
|
|
2024
Q4 | $1.32M | Buy |
8,636
+3,071
| +55% | +$470K | 0.02% | 553 |
|
|
2024
Q3 | $1.08M | Buy |
+5,565
| New | +$1.08M | 0.01% | 571 |
|
|
2019
Q3 | $3.53M | Sell |
15,166
-20,800
| -58% | -$4.84M | 0.03% | 295 |
|
|
2019
Q2 | $8.41M | Buy |
35,966
+11,763
| +49% | +$2.75M | 0.08% | 197 |
|
|
2019
Q1 | $5.72M | Sell |
24,203
-685
| -3% | -$162K | 0.06% | 230 |
|
|
2018
Q4 | $7.49M | Buy |
24,888
+180
| +0.7% | +$54.2K | 0.08% | 196 |
|
|
2018
Q3 | $8.73M | Buy |
+24,708
| New | +$8.73M | 0.08% | 206 |
|
|
2018
Q2 | – | Sell |
-28,718
| Closed | -$7.86M | – | 845 |
|
|
2018
Q1 | $7.86M | Buy |
28,718
+3,330
| +13% | +$912K | 0.07% | 211 |
|
|
2017
Q4 | $8.09M | Buy |
25,388
+15,560
| +158% | +$4.96M | 0.07% | 214 |
|
|
2017
Q3 | $3.08M | Buy |
9,828
+8,707
| +777% | +$2.73M | 0.03% | 307 |
|
|
2017
Q2 | $304K | Sell |
1,121
-26,196
| -96% | -$7.1M | ﹤0.01% | 833 |
|
|
2017
Q1 | $7.47M | Buy |
+27,317
| New | +$7.47M | 0.07% | 210 |
|
|
2015
Q3 | – | Sell |
-530
| Closed | -$214K | – | 969 |
|
|
2015
Q2 | $214K | Buy |
+530
| New | +$214K | ﹤0.01% | 846 |
|
|
2014
Q3 | – | Sell |
-1,403
| Closed | -$442K | – | 893 |
|
|
2014
Q2 | $442K | Buy |
+1,403
| New | +$442K | ﹤0.01% | 753 |
|
|
2014
Q1 | – | Sell |
-840
| Closed | -$235K | – | 937 |
|
|
2013
Q4 | $235K | Sell |
840
-14,746
| -95% | -$4.13M | ﹤0.01% | 755 |
|
|
2013
Q3 | $3.75M | Buy |
+15,586
| New | +$3.75M | 0.04% | 165 |
|